Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adrenoleukodystrophy: phenotypic variability and implications for therapy.

H W Moser1, A B Moser, K D Smith

  • 1Kennedy Institute, Johns Hopkins University, Baltimore, MD 21205.

Journal of Inherited Metabolic Disease
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect-directed analysis of ginger (Zingiber officinale) and its food products, and quantification of bioactive compounds via high-performance thin-layer chromatography and mass spectrometry.

Food chemistry·2017
Same author

Rasmussen's encephalitis presenting as focal cortical dysplasia.

Epilepsy & behavior case reports·2015
Same author

Fatty acids and TxA(2) generation, in the absence of platelet-COX-1 activity.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2013
Same author

Gene expression biomarkers of response to citalopram treatment in major depressive disorder.

Translational psychiatry·2012
Same author

Higher evening antiepileptic drug dose for nocturnal and early-morning seizures.

Epilepsy & behavior : E&B·2011
Same author

Docosahexaenoic acid therapy in peroxisomal diseases: results of a double-blind, randomized trial.

Neurology·2010
Same journal

Beyond Upper Airway Involvement: Evidence of Intrinsic Lung Disease in a Mouse Model of Mucopolysaccharidosis I.

Journal of inherited metabolic disease·2026
Same journal

Immune Dysregulation in Branched Chain Organic Acidemias.

Journal of inherited metabolic disease·2026
Same journal

Long Term Follow-Up After Transplantation in Propionic Acidemia: A Retrospective French Pediatric and Adult Cohort Study.

Journal of inherited metabolic disease·2026
Same journal

Tri-Parametric Assessment of α-Galactosidase A Activity, lysoGb3 and X-Inactivation Aids Genotype-Phenotype Categorization of Fabry Disease Female Patients.

Journal of inherited metabolic disease·2026
Same journal

Mapping the Severity of Phenylalanine Hydroxylase Deficiency.

Journal of inherited metabolic disease·2026
Same journal

Gaucher Disease Treated With Lentiviral-Mediated Gene Therapy: First Case.

Journal of inherited metabolic disease·2026
See all related articles

X-linked adrenoleukodystrophy (ALD) has variable forms, including childhood cerebral and adult-onset adrenomyeloneuropathy (AMN). Research suggests an autosomal modifier locus and explores dietary and bone marrow transplant therapies for ALD.

Area of Science:

  • Genetics and Molecular Biology
  • Neurology
  • Metabolic Disorders

Background:

  • X-linked adrenoleukodystrophy (ALD) is a genetic disorder with significant phenotypic variability.
  • It presents as a rapidly progressive childhood cerebral form or a slowly progressing adult-onset adrenomyeloneuropathy (AMN).
  • These forms often coexist within families, suggesting underlying genetic modifiers.

Purpose of the Study:

  • To investigate the genetic basis of phenotypic variability in X-linked adrenoleukodystrophy.
  • To evaluate the efficacy of dietary interventions and bone marrow transplantation in managing ALD.
  • To identify potential therapeutic strategies for the severe cerebral form of ALD.

Main Methods:

  • Segregation analysis of 3862 individuals across 89 kindreds to identify modifier loci.

Related Experiment Videos

  • Dietary therapy involving mono-unsaturated fatty acids and restricted very long-chain fatty acids intake in 204 patients.
  • Bone marrow transplantation in 14 patients with varying stages of ALD.

    • Main Results:

    • Segregation analysis suggests an autosomal modifier locus influencing ALD phenotype (likelihood ratio 20:1).
    • Dietary regimen normalized plasma very long-chain fatty acids and showed potential improvement in peripheral nerve function in AMN.
    • Preliminary bone marrow transplantation results indicate a potential to halt disease progression in early-stage neurological involvement.

    Conclusions:

    • An autosomal modifier locus likely contributes to the phenotypic diversity of X-linked adrenoleukodystrophy.
    • Dietary therapy shows promise for AMN and warrants further investigation for preventing neurological onset.
    • Bone marrow transplantation offers preliminary hope for halting disease progression, but effective treatments for cerebral ALD remain elusive.